36 Einträge gefunden

1. PO-31: The small-molecule FXIa inhibitor, BMS-26208, prevents tumor cell-induced coagulation activation predominantly in tumor entities with lower tissue factor (TF) expression

   1. Mäder, J
   2. Voigtländer, Minna
   3. Rolling, C
   4. Quick, H
   5. Schulenkorf, A
   6. Lehr, C
   7. Bokemeyer, C

   2022 - Forschungsinformationssystem des UKE
2. Effects of a communication training for oncologists on early addressing palliative and end-of-life care in advanced cancer care (PALLI-COM): a randomized, controlled trial

   1. Harnischfeger, N
   2. Rath, H M
   3. Alt-Epping, B
   4. Brand, H
   5. Haller, K
   6. Letsch, A
   7. Rieder, N

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
3. Testicular seminoma and non-seminoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up

   1. Oldenburg, J
   2. Berney, D M
   3. Bokemeyer, C
   4. Climent, M A
   5. Daugaard, G
   6. Gietema, J A
   7. De Giorgi, U

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
4. Diagnosis and treatment of rare testicular tumors using the example of malignant mesothelioma of the tunica vaginalis testis and Sertoli cell tumors, Diagnose und Therapie seltener Hodentumoren am Beispiel des malignen Mesothelioms der Tunica vaginalis testis und Sertoli-Zell-Tumoren

   1. von Amsberg, G
   2. Sehovic, M
   3. Hartmann, M
   4. Bokemeyer, C

   2021 - Forschungsinformationssystem des UKE
5. Supportive care in patients with cancer during the COVID-19 pandemic

   1. Aapro, M
   2. Lyman, G H
   3. Bokemeyer, C
   4. Rapoport, B L
   5. Mathieson, N
   6. Koptelova, N
   7. Cornes, P

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
6. Thoughts of death and suicidality among patients with cancer: examining subtypes and their association with mental disorders

   1. Vehling, S
   2. Mehnert-Theuerkauf, A
   3. Glaesmer, H
   4. Bokemeyer, C
   5. Oechsle, K
   6. Härter, M
   7. Koch-Gromus, Uwe

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
7. Increased frequency of TIGIT+CD73-CD8+ T cells with a TOX+ TCF-1low profile in patients with newly diagnosed and relapsed AML

   1. Brauneck, F
   2. Haag, F
   3. Woost, R
   4. Wildner, N
   5. Tolosa, E
   6. Rissiek, A
   7. Vohwinkel, G

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
8. Tumor vaccines-therapeutic vaccination against cancer, Tumorvakzinierung – therapeutische Vakzinierung gegen Krebs

   1. Rammensee, H-G
   2. Löffler, M W
   3. Walz, J S
   4. Bokemeyer, C
   5. Haen, S P
   6. Gouttefangeas, C

   2020 - Forschungsinformationssystem des UKE
9. Epigenetic treatment combinations to effectively target cisplatin-resistant germ cell tumors: past, present, and future considerations

   1. Oing, C
   2. Skowron, M A
   3. Bokemeyer, C
   4. Nettersheim, D

   2019 - Forschungsinformationssystem des UKE
10. Positron emission tomography in germ cell tumors in men:Possibilities and limitations, Positronenemissionstomographie bei Keimzelltumoren des Mannes: Einsatzmöglichkeiten und Grenzen

    1. Schriefer, P
    2. Hartmann, M
    3. Oechsle, K
    4. Meyer, C P
    5. Klutmann, S
    6. Fisch, M
    7. Bokemeyer, C

    2019 - Forschungsinformationssystem des UKE
11. Impact of Primary Metastatic Bone Disease in Germ Cell Tumors: Results of an International Global Germ Cell Tumor Collaborative Group G3 Registry Study

    1. Oing, C
    2. Oechsle, K
    3. Necchi, A
    4. Loriot, Y
    5. De Giorgi, U
    6. Fléchon, A
    7. Daugaard, G

    2017 - Forschungsinformationssystem des UKE
12. Prognostic impact of progression to induction chemotherapy and prior paclitaxel therapy in patients with germ cell tumors receiving salvage high-dose chemotherapy in the last 10 years: a study of the European Society for Blood and Marrow Transplantation Solid Tumors Working Party

    1. Necchi, A
    2. Miceli, R
    3. Bregni, M
    4. Bokemeyer, C
    5. Berger, L A
    6. Oechsle, K
    7. Schumacher, K

    2016 - Forschungsinformationssystem des UKE
13. Detrimental social interactions predict loss of dignity among patients with cancer

    1. Philipp, R
    2. Mehnert, Anja
    3. Lehmann, C
    4. Oechsle, K
    5. Bokemeyer, C
    6. Krüll, A
    7. Vehling, S

    2016 - Forschungsinformationssystem des UKE - frei zugänglich
14. Predictive modeling of the outcomes of chemotherapy-induced (febrile) neutropenia prophylaxis with biosimilar filgrastim (MONITOR-GCSF study)

    1. Aapro, M
    2. Ludwig, H
    3. Bokemeyer, C
    4. Gascón, P
    5. Boccadoro, M
    6. Denhaerynck, K
    7. Krendyukov, A

    2016 - Forschungsinformationssystem des UKE - frei zugänglich
15. Improved nutrition in adolescents and young adults after childhood cancer - INAYA study

    1. Quidde, J
    2. von Grundherr, J
    3. Koch, B
    4. Bokemeyer, C
    5. Escherich, Gabriele
    6. Valentini, L
    7. Buchholz, D

    2016 - Forschungsinformationssystem des UKE - frei zugänglich
16. Clinical response to ibrutinib is accompanied by normalization of the T-cell environment in CLL-related autoimmune cytopenia

    1. Schliffke, S
    2. Akyüz, N
    3. Ford, C T
    4. Mährle, T
    5. Thenhausen, T
    6. Krohn-Grimberghe, A
    7. Knop, S

    2016 - Forschungsinformationssystem des UKE
17. Expression and release of platelet protein disulphide isomerase in patients with haemophilia A

    1. Voigtländer, Minna
    2. Holstein, K
    3. Spath, B
    4. Bokemeyer, C
    5. Langer, F

    2016 - Forschungsinformationssystem des UKE
18. The impact of social factors on outcomes in patients with bleeding disorders

    1. Holstein, K
    2. von Mackensen, S
    3. Bokemeyer, C
    4. Langer, F

    2016 - Forschungsinformationssystem des UKE
19. Abituzumab combined with cetuximab plus irinotecan versus cetuximab plus irinotecan alone for patients with KRAS wild-type metastatic colorectal cancer: the randomised phase I/II POSEIDON trial

    1. Élez, E
    2. Kocáková, I
    3. Höhler, T
    4. Martens, U M
    5. Bokemeyer, C
    6. Van Cutsem, E
    7. Melichar, B

    2015 - Forschungsinformationssystem des UKE - frei zugänglich
20. FOLFOX4 plus cetuximab treatment and RAS mutations in colorectal cancer

    1. Bokemeyer, C
    2. Köhne, C-H
    3. Ciardiello, F
    4. Lenz, H-J
    5. Heinemann, V
    6. Klinkhardt, U
    7. Beier, F

    2015 - Forschungsinformationssystem des UKE